News
2d
Zacks Investment Research on MSNHere is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Psoriasis Treatment Market Rising psoriasis prevalence and increasing adoption of biologics are fueling strong growth in the global psorias ...
15h
Zacks.com on MSNDoes Cobenfy Have the Potential to Become a Top Drug for BMY?
Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline ...
Evolus Inc. lost a third of its value after lower-than-expected second quarter results, reflecting weakened demand within the ...
Key drivers in the dementia and movement disorder treatment market include a growing geriatric population and new public awareness strategies. The report features a detailed analysis of major vendors ...
The global monoclonal antibody therapeutics market is set to witness a growth rate of ~12% in the next 5 years. Rising ...
Glenmark Pharmaceuticals to close ISB 2001 transaction in September, focusing on high-margin branded products for growth.
4d
TipRanks on MSNAbbVie, Dow, Kratos, Rocket, Applied Materials: Trending by Analysts
Analysts are intrested in these 5 stocks: ( ($ABBV) ), ( ($DOW) ), ( ($KTOS) ), ( ($RKT) ) and ( ($AMAT) ). Here is a breakdown of their recent ...
AbbVie Inc. has turned heads recently with a notable uptick in stock searches. Over the last month, its shares soared by +9.2 ...
AbbVie Inc. is in the spotlight as Cantor Fitzgerald revises its FY2025 EPS forecast upwards. Analysts now anticipate $12.05 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results